Drug Information

Drug General Information
Drug ID
D0H6AG
Former ID
DIB018011
Drug Name
compound 11d
Drug Type
Small molecular drug
Indication Cardiovascular disorder [ICD10:I00-I99] Clinical trial [532465]
Structure
Download
2D MOL
Formula
C27H36F4N2O4S
InChI
InChI=1S/C27H36F4N2O4S/c1-26(2,3)19-7-5-6-16(9-19)12-33-21-15-38(35)14-18(25(21)34)8-17-10-20(28)24(32)22(11-17)37-23(13-36-4)27(29,30)31/h5-7,9-11,18,21,23,25,33-34H,8,12-15,32H2,1-4H3/t18-,21+,23-,25+,38-/m1/s1
InChIKey
FIUDDEQHPBHZBI-XPLIUGCLSA-N
PubChem Compound ID
51003469
PubChem Substance ID
117686718, 163831581, 174524239, 175452736, 178103528, 224362782, 226647896, 243523762
Target and Pathway
Target(s) Beta-secretase Target Info Inhibitor [532465]
References
Ref 532465Discovery of cyclic sulfoxide hydroxyethylamines as potent and selective beta-site APP-cleaving enzyme 1 (BACE1) inhibitors: structure based design and in vivo reduction of amyloid beta-peptides. Bioorg Med Chem Lett. 2013 Oct 1;23(19):5300-6.
Ref 532465Discovery of cyclic sulfoxide hydroxyethylamines as potent and selective beta-site APP-cleaving enzyme 1 (BACE1) inhibitors: structure based design and in vivo reduction of amyloid beta-peptides. Bioorg Med Chem Lett. 2013 Oct 1;23(19):5300-6.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.